S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

Subrata Ghosh

doi:10.14309/01.ajg.0000860368.55128.7d

S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

Subrata Ghosh

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.14309/01.ajg.0000860368.55128.7d
Publication status	Published - 2022

Keywords

Medicine
Ustekinumab
Concomitant
Internal medicine
Bristol-Myers
Psoriatic arthritis
Tuberculosis
Inflammatory bowel disease
Ulcerative colitis
Psoriasis
Surgery
Gastroenterology
Adalimumab
Disease
Dermatology
Pathology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.14309/01.ajg.0000860368.55128.7d

https://openalex.org/W4316086191Licence: CC BY-NC-ND

Cite this

@article{35aa9356bd0f434ea9c252910ddbb47c,

title = "S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications",

keywords = "Medicine, Ustekinumab, Concomitant, Internal medicine, Bristol-Myers, Psoriatic arthritis, Tuberculosis, Inflammatory bowel disease, Ulcerative colitis, Psoriasis, Surgery, Gastroenterology, Adalimumab, Disease, Dermatology, Pathology",

author = "Subrata Ghosh",

year = "2022",

doi = "10.14309/01.ajg.0000860368.55128.7d",

language = "English",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

}

TY - JOUR

T1 - S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

AU - Ghosh, Subrata

PY - 2022

Y1 - 2022

KW - Medicine

KW - Ustekinumab

KW - Concomitant

KW - Internal medicine

KW - Bristol-Myers

KW - Psoriatic arthritis

KW - Tuberculosis

KW - Inflammatory bowel disease

KW - Ulcerative colitis

KW - Psoriasis

KW - Surgery

KW - Gastroenterology

KW - Adalimumab

KW - Disease

KW - Dermatology

KW - Pathology

U2 - 10.14309/01.ajg.0000860368.55128.7d

DO - 10.14309/01.ajg.0000860368.55128.7d

M3 - Article

SN - 0002-9270

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -